Qtrypta delivers zolmitriptan, a selective 5-HT1B/1D receptor agonist, using the Company’s proprietary Adhesive Dermally-Applied Microarray (ADAM) technology that consists of a drug-coated microneedle patch.
Approximately one-third of patients with migraine reported using opioids to treat their symptoms, a practice that contrasts with current guidelines.
Galcanezumab was found to significantly improve work productivity and reduce interictal burden in patients with treatment-resistant migraine, according to results from the phase 3 CONQUER study.
The bidirectional relationship between migraine and sleep disorders are examined in this article.
Positive results were announced from the phase 3 STOP-301 study evaluating INP104 (intranasal dihydroergotamine mesylate; Impel NeuroPharma) for the treatment of acute migraine in adults.
The investigators observed greater brain activations in the frontal regions associated with cognitive regulation of pain after CBT.
Chiari malformation is a condition characterized by cerebellar tonsillar herniation of ≥5 mm below the level of the foramen magnum.
Researchers evaluated sensory function in the trigeminocervical region in patients with cluster headache, migraine headache, and tension-type headache.
A narrative review summarizes recent data on the pathophysiology, epidemiology, and burden of disease and treatment of menstrual migraine.
Youth with a history of status migranosus are more likely to experience an increase of >4 headache days per month during a follow-up evaluation.
